Ivacaftor and lumacaftor and Piqray 200MG Daily Dose
Determining the interaction of Ivacaftor and lumacaftor and Piqray 200MG Daily Dose and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.GENERALLY AVOID: Coadministration of alpelisib with potent inducers of CYP450 3A4 may significantly reduce the plasma concentrations of alpelisib. The proposed mechanism, based on in vitro data, is increased clearance due to induction of CYP450 3A4, which is one of the routes of metabolism of alpelisib. The therapeutic efficacy of alpelisib may be reduced; however, clinical data are lacking. MANAGEMENT: According to the manufacturer, concomitant use of alpelisib with potent CYP450 3A4 inducers should generally be avoided. Alternative therapeutic agents with less enzyme induction potential should be considered. References "Product Information. Piqray (alpelisib)." Novartis Pharmaceuticals, East Hanover, NJ.
Professional:GENERALLY AVOID: Coadministration of alpelisib with potent inducers of CYP450 3A4 may significantly reduce the plasma concentrations of alpelisib. The proposed mechanism, based on in vitro data, is increased clearance due to induction of CYP450 3A4, which is one of the routes of metabolism of alpelisib. The therapeutic efficacy of alpelisib may be reduced; however, clinical data are lacking.
MANAGEMENT: According to the manufacturer, concomitant use of alpelisib with potent CYP450 3A4 inducers should generally be avoided. Alternative therapeutic agents with less enzyme induction potential should be considered.
- "Product Information. Piqray (alpelisib)." Novartis Pharmaceuticals, East Hanover, NJ.
Generic Name: ivacaftor / lumacaftor
Brand name: Orkambi
Synonyms: Lumacaftor and Ivacaftor
Generic Name: alpelisib
Brand name: Piqray
Synonyms: Alpelisib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ivacaftor and lumacaftor-Piqray 250MG Daily Dose
- Ivacaftor and lumacaftor-Piqray 300MG Daily Dose
- Ivacaftor and lumacaftor-Pirbuterol Inhalation
- Ivacaftor and lumacaftor-Pirfenidone
- Ivacaftor and lumacaftor-Pirmella 1/35
- Ivacaftor and lumacaftor-Pirmella 7/7/7
- Piqray 200MG Daily Dose-Ivacaftor and tezacaftor
- Piqray 200MG Daily Dose-Ivacaftor Granules
- Piqray 200MG Daily Dose-Ivacaftor Tablets
- Piqray 200MG Daily Dose-Ivermectin
- Piqray 200MG Daily Dose-Ivermectin (Systemic)
- Piqray 200MG Daily Dose-Ivermectin Cream